PropertyValue
?:abstract
  • We read with interest the report from Fogarty and colleagues about COVID-19 coagulopathy in Caucasian patients. [1] However, we think that some aspects of this report may deserve further attention. The major concern regards the doses of low-molecular weight heparin (LMWH) used for thromboprophylaxis in this study. Indeed, the Authors report on a weight-adjusted dose of enoxaparin higher than that registered in Europe for the prophylaxis of venous thromboembolism (VTE) in hospitalized acutely ill medical patients.
?:creator
?:doi
  • 10.1111/bjh.16772
?:doi
?:journal
  • Br_J_Haematol
?:license
  • no-cc
?:pdf_json_files
  • document_parses/pdf_json/26a4f66248df99823a95cbf05af7ad9cf3e36270.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7272936.xml.json
?:pmcid
?:pmid
?:pmid
  • 32392353.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • More on: ‘COVID‐19 coagulopathy in Caucasian patients’
?:type
?:year
  • 2020-05-22

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/ajezk7kr>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/ajezk7kr>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all